Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast

Details for Australian Patent Application No. 2005224672 (hide)

Owner GlycoFi, Inc.

Inventors Hamilton, Stephen R.

Agent Cullens

Pub. Number AU-B-2005224672

PCT Pub. Number WO2005/090552

Priority 60/554,139 17.03.04 US

Filing date 17 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 2 June 2011

International Classifications

C12N 1/14 (2006.01) Micro-organisms, e.g. protozoa - Fungi

C12N 9/12 (2006.01) Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

C12N 9/16 (2006.01) Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

C12N 9/88 (2006.01) Enzymes, e.g. ligases (6.) - Lyases (4.)

C12N 9/90 (2006.01) Enzymes, e.g. ligases (6.) - Isomerases (5.)

C12N 15/52 (2006.01) Mutation or genetic engineering - Genes encoding for enzymes or proenzymes

C12P 19/26 (2006.01) Preparation of compounds containing saccharide radicals

C12P 21/00 (2006.01) Preparation of peptides or proteins

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/090552 Priority application(s): WO2005/090552

2 June 2011 Application Accepted

  Published as AU-B-2005224672

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224673-Wireless electrolytic cell monitoring powered by ultra low bus voltage

2005224670-Method for making high purity cardiomyocyte preparations suitable for regenerative medicine